• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Responders and non-responders to drug treatment in social phobia: differences at baseline and prediction of response.

作者信息

Slaap B R, van Vliet I M, Westenberg H G, Den Boer J A

机构信息

Department of Biological Psychiatry, Academic Hospital Groningen, The Netherlands.

出版信息

J Affect Disord. 1996 Jun 20;39(1):13-9. doi: 10.1016/0165-0327(96)00013-4.

DOI:10.1016/0165-0327(96)00013-4
PMID:8835649
Abstract

Differences between responders and non-responders to drug therapy were investigated in social phobia. Two previously published studies were pooled to obtain data of 30 patients who were treated for 12 weeks with brofaromine or fluvoxamine. Four criterion variables were used to divide patients in responders and non-responders. Depending on the criterion variable up to 72% of the patients were regarded as responders. Non-responders differed from responders in that they had a higher heart rate and a higher blood pressure. They were also characterized by higher scores on several psychometric scales, indicative of illness severity.

摘要

相似文献

1
Responders and non-responders to drug treatment in social phobia: differences at baseline and prediction of response.
J Affect Disord. 1996 Jun 20;39(1):13-9. doi: 10.1016/0165-0327(96)00013-4.
2
Social phobia: the clinical efficacy and tolerability of the monoamine oxidase -A and serotonin uptake inhibitor brofaromine. A double-blind placebo-controlled study.社交恐惧症:单胺氧化酶-A与5-羟色胺摄取抑制剂溴法罗明的临床疗效及耐受性。一项双盲安慰剂对照研究。
Acta Psychiatr Scand. 1995 Nov;92(5):351-8. doi: 10.1111/j.1600-0447.1995.tb09596.x.
3
Fluvoxamine treatment of social phobia (social anxiety disorder): a double-blind, placebo-controlled study.氟伏沙明治疗社交恐惧症(社交焦虑障碍):一项双盲、安慰剂对照研究。
Am J Psychiatry. 1999 May;156(5):756-60. doi: 10.1176/ajp.156.5.756.
4
A double-blind comparative study of brofaromine and fluvoxamine in outpatients with panic disorder.溴法罗明与氟伏沙明治疗惊恐障碍门诊患者的双盲对照研究。
J Clin Psychopharmacol. 1996 Aug;16(4):299-306. doi: 10.1097/00004714-199608000-00005.
5
Recent developments in the psychopharmacology of social phobia.社交恐惧症心理药理学的最新进展。
Eur Arch Psychiatry Clin Neurosci. 1995;244(6):309-16. doi: 10.1007/BF02190409.
6
Psychopharmacological treatment of social phobia: clinical and biochemical effects of brofaromine, a selective MAO-A inhibitor.社交恐惧症的心理药理学治疗:选择性单胺氧化酶-A抑制剂溴法罗明的临床及生化效应
Eur Neuropsychopharmacol. 1992 Mar;2(1):21-9. doi: 10.1016/0924-977x(92)90032-4.
7
MHPG and heart rate as correlates of nonresponse to drug therapy in panic disorder patients. A preliminary report.3-甲氧基-4-羟基苯乙二醇(MHPG)与心率作为惊恐障碍患者药物治疗无反应的相关因素。初步报告。
Psychopharmacology (Berl). 1996 Oct;127(4):353-8. doi: 10.1007/s002130050097.
8
The use of the reversible monoamine oxidase-A inhibitor brofaromine in social phobia complicated by panic disorder with or without agoraphobia.可逆性单胺氧化酶-A抑制剂溴法罗明在伴有或不伴有广场恐怖症的惊恐障碍并发社交恐惧症中的应用。
J Clin Psychopharmacol. 1994 Feb;14(1):74-5. doi: 10.1097/00004714-199402000-00011.
9
Phobic symptoms as predictors of nonresponse to drug therapy in panic disorder patients (a preliminary report).惊恐障碍患者中恐惧症状作为药物治疗无反应的预测因素(初步报告)
J Affect Disord. 1995 Jan 11;33(1):31-8. doi: 10.1016/0165-0327(94)00070-p.
10
Personality traits in social phobia, II: Changes during drug treatment.社交恐惧症中的人格特质,II:药物治疗期间的变化。
J Clin Psychiatry. 1995 Dec;56(12):569-73.

引用本文的文献

1
Pharmacotherapy for social anxiety disorder: Interpersonal predictors of outcome and the mediating role of the working alliance.社交焦虑障碍的药物治疗:结局的人际预测因子和工作联盟的中介作用。
J Anxiety Disord. 2017 Dec;52:79-87. doi: 10.1016/j.janxdis.2017.10.004. Epub 2017 Nov 6.
2
Early Improvement in One Week Predicts the Treatment Response to Escitalopram in Patients with Social Anxiety Disorder: A Preliminary Study.社交焦虑障碍患者一周内的早期改善可预测艾司西酞普兰的治疗反应:一项初步研究
Clin Psychopharmacol Neurosci. 2016 May 31;14(2):161-7. doi: 10.9758/cpn.2016.14.2.161.
3
Long-term effectiveness and outcome predictors of therapist-guided internet-based cognitive-behavioural therapy for social anxiety disorder in routine psychiatric care.
常规精神科护理中,治疗师指导的基于互联网的社交焦虑障碍认知行为疗法的长期疗效及结果预测因素
BMJ Open. 2015 Jun 23;5(6):e007902. doi: 10.1136/bmjopen-2015-007902.
4
Brain serotonergic and dopaminergic modulators, perceptual responses and endurance exercise performance following caffeine co-ingested with a high fat meal in trained humans.在经过训练的人类中,咖啡因与高脂肪餐共同摄入后对大脑血清素能和多巴胺能调节剂、感知反应和耐力运动表现的影响。
J Int Soc Sports Nutr. 2010 May 27;7:22. doi: 10.1186/1550-2783-7-22.
5
Brain serotonin and dopamine modulators, perceptual responses and endurance performance during exercise in the heat following creatine supplementation.补充肌酸后在热环境中运动期间脑血清素和多巴胺调节剂、知觉反应及耐力表现
J Int Soc Sports Nutr. 2008 Sep 30;5:14. doi: 10.1186/1550-2783-5-14.
6
Predictors of pharmacotherapy response in anxiety disorders.
Curr Psychiatry Rep. 2005 Aug;7(4):252-7. doi: 10.1007/s11920-005-0078-4.